An Updated Review on the Mechanisms, Pre‐Clinical and Clinical Comparisons of Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR)
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1867011431246856192 |
|---|---|
| author | Xu Yang Anni Lu Xiao Guan Tianlei Ying Jingrong Pan Mingqian Tan Jun Lu |
| author_facet | Xu Yang Anni Lu Xiao Guan Tianlei Ying Jingrong Pan Mingqian Tan Jun Lu Xu Yang Anni Lu Xiao Guan Tianlei Ying Jingrong Pan Mingqian Tan Jun Lu |
| collection | Wiley Open Access |
| contents | An Updated Review on the Mechanisms, Pre‐Clinical and Clinical Comparisons of Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR) Xu Yang Anni Lu Xiao Guan Tianlei Ying Jingrong Pan Mingqian Tan Jun Lu Food Frontiers ABSTRACTThe study of nicotinamide adenine dinucleotide (NAD+) biology has gained popularity recently. Research discovered that two NAD+ biosynthesis intermediates, nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), are biosynthetic precursors of NAD+, an essential chemical for metabolism. Many studies show that NAD+ levels fall considerably with aging, with NAD+ regeneration in aging animals increasing longevity and enhancing health. According to research on the two molecules, NMN and NR, supplementation with either raises NAD+ levels during aging. The objective of this review is to highlight current developments in the biology of NAD+ in relation to NR or NMN supplement. This review highlightings significant discoveries about NR and NMN supplementation in relation to NAD+ biological activities and health benefits. 10.1002/fft2.511 http://creativecommons.org/licenses/by/4.0/ |
| doi_str_mv | 10.1002/fft2.511 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_fft2_511 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by/4.0/ |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | An Updated Review on the Mechanisms, Pre‐Clinical and Clinical Comparisons of Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR) Xu Yang Anni Lu Xiao Guan Tianlei Ying Jingrong Pan Mingqian Tan Jun Lu Food Frontiers An Updated Review on the Mechanisms, Pre‐Clinical and Clinical Comparisons of Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR) Xu Yang Anni Lu Xiao Guan Tianlei Ying Jingrong Pan Mingqian Tan Jun Lu Food Frontiers ABSTRACTThe study of nicotinamide adenine dinucleotide (NAD+) biology has gained popularity recently. Research discovered that two NAD+ biosynthesis intermediates, nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN), are biosynthetic precursors of NAD+, an essential chemical for metabolism. Many studies show that NAD+ levels fall considerably with aging, with NAD+ regeneration in aging animals increasing longevity and enhancing health. According to research on the two molecules, NMN and NR, supplementation with either raises NAD+ levels during aging. The objective of this review is to highlight current developments in the biology of NAD+ in relation to NR or NMN supplement. This review highlightings significant discoveries about NR and NMN supplementation in relation to NAD+ biological activities and health benefits. 10.1002/fft2.511 http://creativecommons.org/licenses/by/4.0/ |
| title | An Updated Review on the Mechanisms, Pre‐Clinical and Clinical Comparisons of Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR) |
| topic | Food Frontiers |
| url | https://iadns.onlinelibrary.wiley.com/doi/10.1002/fft2.511 |